United States · Series A startup

Who invested in Corsera Health

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$80Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $80MJan 2026
Investors
1
See who backed them

The rounds

  1. Jan 2026
    Series A$80M

    Source recorded

Founders and team

From Corsera Health's own website: 3 founders, 6 on the team.

Clive MeanwellCo-Founder and Co-CEO
John MaraganoreCo-Founder and Co-CEO
Chris CoxCo-Founder and Legal Counsel
  • Meredith KayaChief Financial Officer
  • Rena DenoncourtChief Operating Officer
  • Sergio FazioChief Medical Officer
  • Ashlan MusanteHead of Program & Alliance Management
  • Jason CostiganHead of CMC
  • Khurram NasirCo-Chair

AdvisersHans-Peter VornlocherBrian FerencePeter Wijngaard

Everyone who backed them

Forbion Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Corsera Health

Who invested in Corsera Health?

Corsera Health's investors include Forbion Capital Partners.

How much has Corsera Health raised?

Corsera Health has raised $80M across 1 round since 2026.

When did Corsera Health last raise?

Corsera Health's most recent round was a Series A of $80M in Jan 2026.

What was Corsera Health's biggest round?

Its most recent round, $80M in Jan 2026, is also its largest on record.

Who backed Corsera Health first?

Corsera Health's first round on record, in Jan 2026, was backed by Forbion Capital Partners.

What stage is Corsera Health at?

Corsera Health's latest named round is a Series A, in Jan 2026.

Where is Corsera Health based?

Corsera Health is based in the United States.

Companies like Corsera Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.